Top Stories India prepared for impact of Fed policy shift: Rajan RBI governor Raghuram Rajan expects volatility in the Indian financial market if US Federal Reserve raises interest rate, according to a media report. India is well prepared to ... India Infoline, 1 week ago
1 images for "biotechnology regulatory authority of india b"
RNS Press Release 26 March 2015 Interim Results to 31 December 2014 Epistem Holdings Plc (LSE: EHP), the biotechnology and personalised medicine company, announces today its unaudited interim results for the six months to 31 December 2014. The ...MoneyAM, 1 day ago EpiStem : Half Yearly Report 4 Traders, 1 day ago Epistem Holdings plc Half Yearly Report ADVFN UK, 1 day ago Murray Income Trust PLC Half Yearly Report ADVFN UK, 1 month ago
By Last year, 2014, marked the nineteenth year of the successful commercialisation of biotech crops. There has been a more than a hundred-fold increase in the area under these crops. Since 1996, this has expanded from 1.7 million hectares to 181.5 ...Uganda Daily Monitor, 1 month ago
LEXINGTON, Mass., Feb. 24, 2015 (GLOBE NEWSWIRE) -- Curis, Inc. ( Nasdaq:CRIS ), a biotechnology company focused on the development and commercialization of innovative drug candidates for the treatment of human cancers, today reported its financial ...Franklin Credit Management Corporation, 1 month ago Curis, Inc. Reports Fourth Quarter And Year-End 2014 Financial Results BioSpace, 4 weeks ago
More from: Reuters, Town Hall...and 22 other sources
Preclinical Melioidosis Results Presented at the 2015 ASM Biodefense and Emerging Diseases Research Meeting in Washington, DC
The Company's proprietary innate defense regulator (IDR) technology, including SGX943, have been specifically developed to target the host response to infection (not the bacteria) making them broadly applicable to many bacterial infections.Morningstar.com, 1 month ago 12635 E. Montview Blvd. Release: Preclinical Melioidosis Results Presented At The 2015 Biodefense And Emerging Diseases Research Meeting In Washington, DC BioSpace, 1 month ago SOLIGENIX : Preclinical Melioidosis Results Presented at the 2015 ASM Biodefense and Emerging Diseases Research Meeting in Washington, DC 4 Traders, 1 month ago Soligenix Announces Presentation and Poster at the 2015 ASM Biodefense and Emerging Diseases Research Meeting in Washington, DC Financial Content, 1 month ago
More from: Finwin, Minyanville...and 37 other sources
Posted 25/04/2014 Russian biotechnology company Biocad announced on 17 April 2014 that the Russian Ministry of Health has approved the company's rituximab non-originator biological, AcellBia (BCD-020). The drug is a non-originator biological of ...GaBi Online, 1 month ago
Vaccine Manufacturing and Production is an invaluable reference on how to produce a vaccine - from beginning to end - addressing all classes of vaccines from a processing,production, and regulatory viewpoint. It will provide comprehensive ...Research and Markets, 1 month ago
FEATURED COMPANIES A. R. Life Sciences Biocon Elder Pharmaceuticals Hikal Mangalam Drugs & Organics Shasun Pharmaceuticals MORE About Active Pharmaceutical Ingredients ...Research and Markets, 2 months ago
Predictions And Outlook For EPA's Office Of Chemical Safety And Pollution Prevention (OCSPP) 2015: 2015 will be a very interesting year. There are two overarching considerations that will make the year more difficult to predict than merely assuming ...JD Supra, 2 months ago
Posted by admin on · Leave a Comment Director Research, Dean Social Sciences and Professor, CVMS, IASE Deemed University, Rajasthan, India. email@example.com /http://existentialharmony.org / . . Abstract : Mother earth is ...Global Education Magazine, 5 days ago
on your WebpageAdd Widget >Get your members hooked!